Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
5 hedge funds and large institutions have $13.3K invested in Biotricity, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 18 closing their positions.
77% less funds holding
Funds holding: 22 → 5 (-17)
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 18
96% less capital invested
Capital invested by funds: $369K → $13.3K (-$356K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPIA
Steward Partners Investment Advisory
New York
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$92.3K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$87.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$65K |
| 4 |
State Street
Boston,
Massachusetts
|
-$20.3K |
| 5 |
BlackRock
New York
|
-$12K |
BTCY Hedge Fund Activity: Q3 2024 in Review
5 of the 6,962 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q3 2024, worth a combined $13.3K — down 96% from $369K a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of BTCY and 1 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Steward Partners Investment Advisory, opening a new position worth an estimated $10. The largest seller was Vanguard Group, exiting entirely with an estimated $92.3K sold.
- 5 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q3 2024, down from 22 in Q2 2024.
- Funds reported $13.3K of Biotricity, Inc. Common Stock stock for Q3 2024, down 96% quarter-over-quarter.
- 1 fund opened new Biotricity, Inc. Common Stock positions in Q3 2024 and 18 closed out, a net change of -17 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q3 2024 was Steward Partners Investment Advisory, an estimated $10 added.
- The largest Biotricity, Inc. Common Stock seller in Q3 2024 was Vanguard Group, an estimated $92.3K sold.
Based on aggregated 13F filings for Q3 2024.